Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
3.75 USD | +0.81% | -1.57% | +108.33% |
May. 14 | Pyxis Oncology, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024 | CI |
May. 14 | Earnings Flash (PYXS) PYXIS ONCOLOGY Posts Q1 Revenue $16.1M | MT |
Business Summary
Number of employees: 51
Managers
Managers | Title | Age | Since |
---|---|---|---|
Lara Sullivan
CEO | Chief Executive Officer | 51 | 19-12-10 |
Pamela Connealy
DFI | Director of Finance/CFO | 62 | 21-06-30 |
Chief Tech/Sci/R&D Officer | - | - | |
Jan Pinkas
CTO | Chief Tech/Sci/R&D Officer | - | 21-07-31 |
Ken Kobayashi
CTO | Chief Tech/Sci/R&D Officer | 63 | Nov. 26 |
Jitendra Wadhane
AUD | Comptroller/Controller/Auditor | 44 | 21-07-31 |
Members of the board
Members of the board | Title | Age | Since |
---|---|---|---|
John Flavin
FOU | Founder | 55 | 18-06-10 |
Freda Lewis-Hall
BRD | Director/Board Member | 69 | 21-08-31 |
Darren Cline
BRD | Director/Board Member | 59 | 21-08-31 |
Jakob Dupont
BRD | Director/Board Member | 58 | 23-08-22 |
Rachel Humphrey
BRD | Director/Board Member | 62 | 22-08-10 |
Thomas Civik
BRD | Director/Board Member | 55 | 21-08-31 |
Lara Sullivan
CEO | Chief Executive Officer | 51 | 19-12-10 |
Share class
Vote | Quantity | Free-Float | Company-owned shares | Total Float | |
---|---|---|---|---|---|
Stock A | 1 | 58,888,473 | 47,203,803 ( 80.16 %) | 0 | 80.16 % |
Company contact information
Sector
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
+108.33% | 220M | |
+11.60% | 106B | |
-4.68% | 24.28B | |
-0.82% | 21.96B | |
-10.12% | 18.16B | |
-42.12% | 16.37B | |
-17.47% | 15.56B | |
+2.77% | 13.63B | |
+34.58% | 12.27B | |
+77.64% | 8.87B |
- Stock Market
- Equities
- PYXS Stock
- Company Pyxis Oncology, Inc.